Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine
β Scribed by Enasio Morris; Digby Green; Andis Graudins
- Publisher
- Springer-Verlag
- Year
- 2009
- Tongue
- English
- Weight
- 201 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1556-9039
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A 30-year-old white man with schizophrenia developed anorexia and nausea, and was admitted to hospital for confusion and delirium. He was on olanzapine, 10 days prior to admission. On admission, typical neuroleptic malignant syndrome (NMS) developed with elevated body temperature (39.7 degrees C), o
Clozapine-induced neuroleptic malignant syndrome not recurring with olanzapine, a structurally and pharmacologically similar antipsychotic
## Abstract ## BACKGROUND Evaluation of therapeutic outcomes and risk factors was undertaken for patients with primary solid tumors (PST) developing acute leukemia or myelodysplasia (MDS) as a second malignancy. ## METHODS In all, 131 consecutive patients presenting to a single institution with